Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|November 10, 2020
Machine-learning algorithms for predicting hospital re-admissions in sickle cell diseaseArisha Patel, Kyra Gan, Andrew A Li, et al.
Cancer|April 6, 2017
The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United StatesJohn A Vargo, Arisha Patel, Scott M Glaser, et al.
JCO Clinical Cancer Informatics|June 1, 2022
Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control ArmYusuke Narita, Takuya Yoshimoto, Tomoyuki Namai, et al.
JCO Clinical Cancer Informatics|March 17, 2022
Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical PracticeCarsten Schröder, Craig Gower-Page, Irmarie Reyes-Rivera, et al.
Oncology Research|August 6, 2020
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete RemissionArisha Patel, Mounzer Agha, Anastasios Raptis, et al.
Cancer Discovery|December 8, 2021
Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket StudyClaire F Friedman, John D Hainsworth, Razelle Kurzrock, et al.
The Lancet. Oncology|August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket studyMilind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Pageof 1